ReviewJournal of personalized medicine2021

From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Bieke Decaesteker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.